Evaluation of a Standardized Protocol for Plasma Rich in Growth Factors Obtention in Cats: A Prospective Study

Overview

Journal Front Vet Sci

Specialty Veterinary Medicine

Date 2022 May 2

PMID 35498746

Authors

Laura Miguel-Pastor

Katy Satue

Deborah Chicharro

Marta Torres-Torrillas

Ayla Del Romero

Pau Pelaez

Jose M Carrillo

Belen Cuervo

Joaquin J Sopena

Jose J Ceron

Monica Rubio

Affiliations

Soon will be listed here.

Abstract

Introduction: Platelet-rich plasma (PRP) is an autologous plasma with platelet (PLT) concentration above that of whole blood (WB). PLTs contain growth factors (GFs) that promote tissular repair.

Objectives: To determine and compare the concentrations of PLT, red blood cells (RBC) and white blood cells (WBC) between WB samples, PRP and platelet poor plasma (PPP) samples; and to analyze the concentrations of platelet-derived growth factor BB (PDGF-BB) and transforming growth factor β1 (TGF-β1) in the PRP and PPP of healthy adult cats using a standardized protocol with PRGF®-Endoret® characteristics.

Material And Methods: WB was collected from 30 cats. PRP was obtained following three centrifugation protocols using PRGF®-Endoret® technology: 255, 260, and 265 g for 10 min each. The cellular components, RBC, WBC, PLT, and the concentrations of PDGF-BB and TGF-β1 in the PRP and PPP fractions were determined for each protocol.

Results: PLTs in the PRP fraction were statistically higher than WB, with no statistical differences between PPP and WB. In PRP fraction, PLT concentration was increased 1.4 times on average at 255 g; 1.3 times at 260 g and, 1.5 times at 265 g without statistical differences among them. The mean platelet volume (MPV) was significantly higher in WB compared to PRP and PPP fractions without significant differences between protocols. Compared to WB, the number of RBCs and WBCs was reduced by 99% and by more than 95% in PRP and PPP respectively, without significant differences between protocols. PDGF-BB concentrations were statistically higher in PRP than in PPP fractions, however, TGF-ß1 concentrations did not vary between fractions at 260 g. Comparing the three protocols within PRP and PPP fractions, no differences in PDGF-BB and TGF-ß1 concentrations were observed.

Clinical Relevance: The study shows scientific evidence regarding the obtention of PRP in cats using the PRGF®-Endoret® technology for the quantification of PDGF-BB and TGF-ß1. At 265 g for 10 min, PLT concentration was increased 1.5 times with unnoticeable erythrocytes and leukocytes in the samples. These results clearly show that the PRGF®-Endoret® methodology is suitable to obtain PRP in cats. Further studies are needed to determine the clinical efficacy of the obtained PGRF in the treatment of different pathologies in cats.

Citing Articles

Evaluation of Platelet-Rich Plasma by means of PRGF-Endoret protocol in leukemia cats: PDGF-BB and TGF-ß1 valuation.

Miguel-Pastor L, Satue K, Chicharro D, Pelaez P, Torres-Torrillas M, Carrillo J Front Vet Sci. 2023; 10:1110055.

PMID: 36777664 PMC: 9909748. DOI: 10.3389/fvets.2023.1110055.

References

Anitua E . Plasma rich in growth factors: preliminary results of use in the preparation of future sites for implants. Int J Oral Maxillofac Implants. 1999; 14(4):529-35. View

Anitua E, Sanchez M, Orive G, Andia I . The potential impact of the preparation rich in growth factors (PRGF) in different medical fields. Biomaterials. 2007; 28(31):4551-60. DOI: 10.1016/j.biomaterials.2007.06.037. View

Carmona J, Rios D, Lopez C, Alvarez M, Perez J, Bohorquez M . In vitro effects of platelet-rich gel supernatants on histology and chondrocyte apoptosis scores, hyaluronan release and gene expression of equine cartilage explants challenged with lipopolysaccharide. BMC Vet Res. 2016; 12(1):135. PMC: 4929746. DOI: 10.1186/s12917-016-0759-8. View

Riond B, Wassmuth A, Hartnack S, Hofmann-Lehmann R, Lutz H . Study on the kinetics and influence of feline platelet aggregation and deaggregation. BMC Vet Res. 2015; 11:276. PMC: 4635602. DOI: 10.1186/s12917-015-0590-7. View

Anitua E, Prado R, Orive G . Plasma rich in growth factors in dogs: Two sides of the same coin. Dent Res J (Isfahan). 2017; 14(6):427-428. PMC: 5713068. DOI: 10.4103/1735-3327.218568. View

Ikumi A, Hara Y, Yoshioka T, Kanamori A, Yamazaki M . Effect of local administration of platelet-rich plasma (PRP) on peripheral nerve regeneration: An experimental study in the rabbit model. Microsurgery. 2017; 38(3):300-309. DOI: 10.1002/micr.30263. View

Filardo G, Kon E, Pereira Ruiz M, Vaccaro F, Guitaldi R, Di Martino A . Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: single- versus double-spinning approach. Knee Surg Sports Traumatol Arthrosc. 2011; 20(10):2082-91. DOI: 10.1007/s00167-011-1837-x. View

Soares C, Babo P, Faria S, Pires M, Carvalho P . Standardized Platelet-Rich Fibrin (PRF) from canine and feline origin: An analysis on its secretome pattern and architectural structure. Cytokine. 2021; 148:155695. DOI: 10.1016/j.cyto.2021.155695. View

Franklin S, Garner B, Cook J . Characteristics of canine platelet-rich plasma prepared with five commercially available systems. Am J Vet Res. 2015; 76(9):822-7. DOI: 10.2460/ajvr.76.9.822. View

10.

Silva R, Carmona J, Rezende C . Intra-articular injections of autologous platelet concentrates in dogs with surgical reparation of cranial cruciate ligament rupture: a pilot study. Vet Comp Orthop Traumatol. 2013; 26(4):285-90. DOI: 10.3415/VCOT-12-06-0075. View

11.

Rossi L, Murray I, Chu C, Muschler G, Rodeo S, Piuzzi N . Classification systems for platelet-rich plasma. Bone Joint J. 2019; 101-B(8):891-896. DOI: 10.1302/0301-620X.101B8.BJJ-2019-0037.R1. View

12.

Jackson S, Carter J . Platelet volume: laboratory measurement and clinical application. Blood Rev. 1993; 7(2):104-13. DOI: 10.1016/s0268-960x(05)80020-7. View

13.

Tvedten H, Ljusner J, Lilliehook I . Enumeration of feline platelets in ethylenediamine tetra-acetic acid anticoagulated blood with the ADVIA 2120 system and two manual methods: Leucoplate and Thrombo-TIC. J Vet Diagn Invest. 2013; 25(4):493-7. DOI: 10.1177/1040638713493419. View

14.

Clemmons R, Bliss E, Seachord C, Meyers K . Platelet function, size and yield in whole blood and in platelet-rich plasma prepared using differing centrifugation force and time in domestic and food-producing animals. Thromb Haemost. 1983; 50(4):838-43. View

15.

Arata S, Ohmi A, Mizukoshi F, Baba K, Ohno K, Setoguchi A . Urinary transforming growth factor-beta1 in feline chronic renal failure. J Vet Med Sci. 2006; 67(12):1253-5. DOI: 10.1292/jvms.67.1253. View

16.

Dohan Ehrenfest D, Andia I, Zumstein M, Zhang C, Pinto N, Bielecki T . Classification of platelet concentrates (Platelet-Rich Plasma-PRP, Platelet-Rich Fibrin-PRF) for topical and infiltrative use in orthopedic and sports medicine: current consensus, clinical implications and perspectives. Muscles Ligaments Tendons J. 2014; 4(1):3-9. PMC: 4049647. View

17.

Sousa S, Sousa T, Silva C, Mendes C . Pseudothrombocytopenia: a case of platelet satellitism and phagocytosis by neutrophils. Platelets. 2019; 31(4):541-543. DOI: 10.1080/09537104.2019.1664733. View

18.

Marx R . Platelet-rich plasma (PRP): what is PRP and what is not PRP?. Implant Dent. 2002; 10(4):225-8. DOI: 10.1097/00008505-200110000-00002. View

19.

Moritz A, Hoffmann C . [Platelet count in the cat]. Tierarztl Prax Ausg K Kleintiere Heimtiere. 1998; 25(6):695-700. View

20.

Ferrari J, Schwartz P . Prospective Evaluation of Feline Sourced Platelet-Rich Plasma Using Centrifuge-Based Systems. Front Vet Sci. 2020; 7:322. PMC: 7303265. DOI: 10.3389/fvets.2020.00322. View